Searched for
ENHERTU
GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...17 Feb, 2025, 01.05 PM IST- Over 3k brands hit pharma mkt, cancer drug tops in salesIndia's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the top-seller, ref...11 Feb, 2025, 11.17 PM IST
- AstraZeneca India recasts biopharma unitAstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. T...30 Dec, 2024, 12.09 AM IST
- AstraZeneca, Daiichi Drug gets broad tumor approval in USEnhertu, a collaboration between AstraZeneca and Daiichi Sankyo, gains FDA approval for treating HER2-positive solid tumors spread througho...08 Apr, 2024, 02.24 PM IST
- Daiichi Sankyo, Merck ink $22-billion cancer drug dealThe deal adds promising drug candidates to Merck's oncology portfolio, as its bestselling cancer therapy Keytruda will see its patent expir...20 Oct, 2023, 11.50 PM IST
- 'Unheard-of' cancer drug trials slow tumor growth, extend life of patientsThe new study would change how medicine was practiced, cancer specialists said.08 Jun, 2022, 07.25 PM IST
- AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.13 Dec, 2020, 07.00 AM IST
Load More
